skip to main content

Rogel Cancer Center at the American Assocation for Cancer Research's Annual Meeting

Date Visible: 
04/10/2018 - 3:30pm

Researchers from the University of Michigan Rogel Cancer Center will attend the American Association for Cancer Research Annual meeting from Sunday, April 14 through Wednesday, April 18. Many of them plan to participate in poster sessions. Scroll down to learn who is presenting, when, where and on what topic.

Wednesday, April 18

Presentations

10:20-10:45 a.m.
Weiping Zou, Metabolic impact on immune cell subsets in the tumor microenvironment and its therapeutic relevance, N Hall C

Poster Sessions 8am - Noon

Andrew E. Goodrum, Evaluating Ago2 as an oncogene in Kras-dependent lung carcinoma
Section 4, poster 8

Ramya Ravindran, Characterization of a mouse model using the Sleeping Beauty transposon method to study diffuse intrinsic pontine glioma (DIPG)
Section 4, poster 10

Hannah Cheriyan, RhoC decreases tight junction stabilization in breast cancer cells, revealing a potential therapeutic target
Section 6, poster 8

Nicole D. Lee, Somatic bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma (ESC RCC)
Section 16, poster 24

Chitra Subramanian, Targeting the kynurenine pathway as a novel metabolic treatment for head and neck cancer
Section 21, poster 11

Sarah Owen, Single cell mutation and gene expression co-analysis of lung circulating tumor cells
Section 26, poster 9

Mina Zeinali, Increased number of EMT-like CTCs relative to epithelial CTCs reveals signatures of poor outcomes in pancreatic cancer
Section 26, poster 11

Steven Kregel, Functional and mechanistic interrogation of BET Bromodomain degraders for the treatment of metastatic castration resistant prostate cancer
Section 36, poster 21

Lanbo Xiao, Epigenetic re-programming sensitizes prostate cancer cells to anti-androgen therapy
Section 38, poster 2

Khaled Hassan, Activation Induced Cytosine Deamination, AICDA, is induced after EGFR TKI exposure leading to secondary resistant mutations in lung adenocarcinoma
Section 38, poster 4

back to top